Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Uncategorized
Childhood Memories
As we prepare for the holiday season, we asked the employees at Rockpointe to share their most memorable Childhood memories, we…
ECHO Improves Rural Physician Access to Subspecialty Expertise
The Project Extension for Community Healthcare Outcomes (ECHO) was started at the University of New Mexico School of Medicine,…
Is Physician Spending Linked to Malpractice Claims?
A 2015 study is coming back to the forefront with a new interview by Dr. Anupam Jena. Dr. Jena authored the 2015 study, Physician…
HHS Issues Open Government Plan
On October 6, 2016, the U.S. Department of Health and Human Services announced its fourth Open Government Plan, which details…
Proposition 61 in California: Should We Be Worried?
With all eyes focused on the impending presidential election, many may be overlooking a perhaps more important impending vote: the…
FDA Raises Issue of Citizen Petitions
In August, the FDA noted its concerns that citizen petitions do not raise valid scientific issues and are used to delay the…
Life Science CEOs “Upbeat” About Industry Prospects
According to KPMG LLP’s U.S. CEO Outlook 2016, CEOs of life science companies are confident about their prospects for growth in…
NPAs and DPAs – An Enforcement Loophole or Compliance Incentive?
The U.S. Department of Justice (DOJ) and the U.S. Securities and Exchange Commission (“SEC”) recently have faced criticism for…
Is Pricing the New Frontier?
“Usual and customary (U&C) pricing” can be a very confusing term, even to executives of specialty pharmacy companies. The term…
The Debate Rages On: Should Clinical Trial Data Be Public?
As we have previously written, the topic of whether or not researchers should make all the data they collect when testing drugs…